Cancer Clinical Trial -PrECOG- PrE0905

Cancer

Status:

Open

ClinicalTrials.gov:

NCT03836209

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

Drug

Gilteritinib, Midostaurin, Daunorubicin, Cytarabine

Phase

Phase II

Condition

Acute Myeloid Leukemia

Keywords

Gilteritinib Midostaurin Daunorubicin Cytarabine FLT3